Journal
Immunology and Infection
Quantifying Vaccine-Induced Neutralizing Antibodies in SARS-CoV-2 Variants

Quantifying Vaccine-Induced Neutralizing Antibodies in SARS-CoV-2 Variants

September 08, 2023

Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research

01:18 min
•
500 Views

Assembling Ha-CoV-2 Particles by Cotransfection of HEK293T Cells for Quantification of SARS-CoV-2 Variants

01:40 min
•
124 Views

Quantification of Ha-CoV-2 Variants and 27BV Neutralization Activity Against Ha-CoV-2(Luc) Variants

03:13 min
•
67 Views
, ,
1Center for Infectious Disease Research, School of Systems Biology,George Mason University

Summary

English

Automatically Generated

This protocol describes the application of a novel hybrid alphavirus-SARS-CoV-2 pseudovirus (Ha-CoV-2) as a platform for rapid quantification of infectivity of SARS-CoV-2 variants and their sensitivity to neutralizing antibodies.

Article